Enovis (ENOV) Revenue Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | 13.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 13.20% |
| Dec 31, 2025 | 12.10% |
| Oct 3, 2025 | 12.67% |
| Jul 4, 2025 | 12.63% |
| Apr 4, 2025 | 14.18% |
| Dec 31, 2024 | 12.02% |
| Sep 27, 2024 | 11.97% |
| Jun 28, 2024 | 13.82% |
| Mar 29, 2024 | 18.39% |
| Dec 31, 2023 | -18.09% |
| Sep 29, 2023 | -19.69% |
| Jun 30, 2023 | -11.60% |
| Mar 31, 2023 | -20.76% |
| Dec 31, 2022 | -22.80% |
| Sep 30, 2022 | -23.18% |
| Jul 1, 2022 | -24.24% |
| Apr 1, 2022 | -18.12% |
| Dec 31, 2021 | -11.46% |
| Oct 1, 2021 | -11.77% |
| Jul 2, 2021 | -14.05% |
| Apr 2, 2021 | -16.44% |
| Dec 31, 2020 | -1.78% |
| Oct 2, 2020 | -1.55% |
| Jul 3, 2020 | -9.89% |
| Apr 3, 2020 | 3.63% |
| Dec 31, 2019 | 3.02% |
| Sep 27, 2019 | 3.36% |
| Jun 28, 2019 | 2.61% |
| Mar 29, 2019 | -3.70% |
| Dec 31, 2018 | -18.49% |
| Sep 28, 2018 | -18.53% |
| Jun 29, 2018 | -18.22% |
| Mar 30, 2018 | -16.35% |
| Dec 31, 2017 | -10.18% |
| Sep 29, 2017 | -10.15% |
| Jun 30, 2017 | -10.91% |
| Mar 31, 2017 | -11.39% |
| Dec 31, 2016 | -11.48% |
| Sep 30, 2016 | -8.92% |
| Jul 1, 2016 | -7.83% |
| Apr 1, 2016 | -6.84% |
| Dec 31, 2015 | 1.09% |
| Sep 25, 2015 | 0.51% |
| Jun 26, 2015 | -0.65% |
| Mar 27, 2015 | 0.92% |
| Dec 31, 2014 | 89.32% |
| Sep 26, 2014 | 89.80% |
| Jun 27, 2014 | 85.88% |
| Mar 28, 2014 | 88.05% |
| Dec 31, 2013 | 91.56% |
| Sep 27, 2013 | 97.15% |
| Jun 28, 2013 | 105.95% |